US stocks opened the week lower, paring back some of the sharp gains from the previous session ahead of a data‑heavy calendar, as investors continued to reassess risks in software names after their recent rout. The S&P 500 and the Dow each slipped 0.3%, while the tech‑heavy Nasdaq 100 underperformed with a 0.5% decline.
In fixed income, Chinese regulators have reportedly urged domestic financial institutions to reduce their exposure to US Treasuries, citing concentration risk and market volatility. The move has reinforced concerns that long‑term borrowing costs for large US corporates could remain elevated over the medium term.
Within equities, software stocks were broadly weaker, extending last week’s selloff as advances in automation tools from Anthropic fueled worries about the outlook for software segments viewed as vulnerable to AI disruption. Intuit and Salesforce each fell more than 2%. By contrast, Eli Lilly gained more than 3.5% after announcing a $2.4 billion all‑cash acquisition of Orna Therapeutics.
